Literature DB >> 33199326

Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19.

Sophie Kelly1, Laura Waters2, Muge Cevik3, Simon Collins4, Joe Lewis1, Meng-San Wu5, Tom J Blanchard1, Anna M Geretti6.   

Abstract

While clinical environments are highly focused on COVID-19, reports of missed or delayed treatment for conditions that imitate COVID-19, such as pneumonia caused by the fungus Pneumocystis jirovecii, are emerging. Given the uncertain spectrum of COVID-19 presentations and variable sensitivity of laboratory tests for SARS-CoV-2, there is a risk that, without a high index of suspicion, alternative aetiologies may be overlooked while pursuing a diagnosis of COVID-19. The British HIV Association has been calling for the inclusion of HIV testing in all patients admitted to hospital with suspected COVID-19. In this article we reflect on the importance of including HIV testing to prevent avoidable morbidity and mortality in our patients. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  COVID-19; HIV; PCP; Pneumocystis jirovecii; SARS-CoV-2

Mesh:

Year:  2020        PMID: 33199326      PMCID: PMC7687333          DOI: 10.7861/clinmed.2020-0565

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  3 in total

1.  Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.

Authors:  R F Miller; E Allen; A Copas; M Singer; S G Edwards
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

2.  Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection.

Authors:  Sebastian Mang; Dominic Kaddu-Mulindwa; Carlos Metz; André Becker; Frederik Seiler; Sigrun Smola; Alexander Maßmann; Sören L Becker; Cihan Papan; Robert Bals; Philipp M Lepper; Guy Danziger
Journal:  Clin Infect Dis       Date:  2021-04-26       Impact factor: 9.079

3.  Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.

Authors:  Harry Coleman; Luke B Snell; Rebecca Simons; Sam T Douthwaite; Ming J Lee
Journal:  AIDS       Date:  2020-07-01       Impact factor: 4.632

  3 in total
  11 in total

1.  Bias in the COVID-19 era.

Authors:  Avinash Aujayeb
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

2.  HIV testing during the COVID-19 pandemic.

Authors:  Sarah Ann Filson; Anika Rahim; Victoria Parris; Alastair McGregor; Padmasayee Papineni
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 3.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

4.  Concurrent COVID-19 and pneumocystis carinii pneumonia in a patient subsequently found to have underlying hairy cell leukemia.

Authors:  Vahan Moradians; Bahareh Shateri Amiri; Leyla Bahadorizadeh; Milad Gholizadeh Mesgarha; Shahrzad Sadeghi
Journal:  Radiol Case Rep       Date:  2022-07-02

Review 5.  State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.

Authors:  Woon H Chong; Biplab K Saha; Amit Chopra
Journal:  Infection       Date:  2021-03-11       Impact factor: 3.553

Review 6.  Pathogenesis of Respiratory Viral and Fungal Coinfections.

Authors:  Fabián Salazar; Elaine Bignell; Gordon D Brown; Peter C Cook; Adilia Warris
Journal:  Clin Microbiol Rev       Date:  2021-11-17       Impact factor: 26.132

7.  Decrease in new diagnosis of HIV/AIDS in the two years period 2019-2020: impact of COVID-19 pandemic.

Authors:  Eugenia Quiros-Roldan; Ilaria Izzo; Canio Carriero; Melania Degli Antoni; Samuele Storti; Giorgio Tiecco; Giulia Gardini; Emanuele Focà; Francesco Castelli
Journal:  J Public Health Res       Date:  2021-09-24

8.  Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.

Authors:  Jing Peng; Ming Ni; Dunfeng Du; Yanjun Lu; Juan Song; Weiyong Liu; Na Shen; Xiong Wang; Yaowu Zhu; Bruce A Vallance; Ziyong Sun; Hong Bing Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-12-15       Impact factor: 3.944

Review 9.  Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals.

Authors:  Francesca Gioia; Hanan Albasata; Seyed M Hosseini-Moghaddam
Journal:  J Fungi (Basel)       Date:  2022-05-30

Review 10.  The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.

Authors:  Nahid Akhtar; Atif Khurshid Wani; Surya Kant Tripathi; Ajit Prakash; M Amin-Ul Mannan
Journal:  Curr Res Biotechnol       Date:  2022-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.